96 related articles for article (PubMed ID: 17077962)
1. Non-sufficient cell cycle control as possible clue for the resistance of human malignant glioma cells to clinically relevant treatment conditions.
Trog D; Moenkemann H; Breipohl W; Schueller H; Schild H; Golubnitschaja O
Amino Acids; 2007; 32(3):373-9. PubMed ID: 17077962
[TBL] [Abstract][Full Text] [Related]
2. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells.
Trog D; Yeghiazaryan K; Fountoulakis M; Friedlein A; Moenkemann H; Haertel N; Schueller H; Breipohl W; Schild H; Leppert D; Golubnitschaja O
Eur J Pharmacol; 2006 Aug; 542(1-3):8-15. PubMed ID: 16806166
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
Roos WP; Batista LF; Naumann SC; Wick W; Weller M; Menck CF; Kaina B
Oncogene; 2007 Jan; 26(2):186-97. PubMed ID: 16819506
[TBL] [Abstract][Full Text] [Related]
4. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment.
Trog D; Moenkemann H; Haertel N; Schüller H; Golubnitschaja O
Amino Acids; 2005 Mar; 28(2):213-9. PubMed ID: 15723240
[TBL] [Abstract][Full Text] [Related]
5. Multifaceted resistance of gliomas to temozolomide.
Bocangel DB; Finkelstein S; Schold SC; Bhakat KK; Mitra S; Kokkinakis DM
Clin Cancer Res; 2002 Aug; 8(8):2725-34. PubMed ID: 12171906
[TBL] [Abstract][Full Text] [Related]
6. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
[TBL] [Abstract][Full Text] [Related]
7. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
Hermisson M; Klumpp A; Wick W; Wischhusen J; Nagel G; Roos W; Kaina B; Weller M
J Neurochem; 2006 Feb; 96(3):766-76. PubMed ID: 16405512
[TBL] [Abstract][Full Text] [Related]
8. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
[TBL] [Abstract][Full Text] [Related]
9. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells.
Hirose Y; Berger MS; Pieper RO
Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752
[TBL] [Abstract][Full Text] [Related]
10. The effect of PTEN on proliferation and drug-, and radiosensitivity in malignant glioma cells.
Inaba N; Kimura M; Fujioka K; Ikeda K; Somura H; Akiyoshi K; Inoue Y; Nomura M; Saito Y; Saito H; Manome Y
Anticancer Res; 2011 May; 31(5):1653-8. PubMed ID: 21617223
[TBL] [Abstract][Full Text] [Related]
11. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
12. Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.
Gramatzki D; Herrmann C; Happold C; Becker KA; Gulbins E; Weller M; Tabatabai G
PLoS One; 2013; 8(5):e63527. PubMed ID: 23667632
[TBL] [Abstract][Full Text] [Related]
13. Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU.
Gomez-Manzano C; Lemoine MG; Hu M; He J; Mitlianga P; Liu TJ; Yung AW; Fueyo J; Groves MD
Int J Oncol; 2001 Aug; 19(2):359-65. PubMed ID: 11445852
[TBL] [Abstract][Full Text] [Related]
14. Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions.
Trog D; Fountoulakis M; Friedlein A; Golubnitschaja O
Proteomics; 2006 May; 6(9):2924-30. PubMed ID: 16596702
[TBL] [Abstract][Full Text] [Related]
15. Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.
Alexiou GA; Gerogianni P; Vartholomatos E; Kyritsis AP
Cancer Invest; 2016 Nov; 34(10):489-495. PubMed ID: 27768402
[TBL] [Abstract][Full Text] [Related]
16. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
Aghi M; Rabkin S; Martuza RL
J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines.
Combs SE; Bohl J; Elsasser T; Weber KJ; Schulz-Ertner D; Debus J; Weyrather WK
Int J Radiat Biol; 2009 Feb; 85(2):126-37. PubMed ID: 19280465
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo.
Rocha CR; Garcia CC; Vieira DB; Quinet A; de Andrade-Lima LC; Munford V; Belizário JE; Menck CF
Cell Death Dis; 2014 Oct; 5(10):e1505. PubMed ID: 25356874
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
20. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.
Han S; Li Z; Master LM; Master ZW; Wu A
Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]